{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:42:34Z","timestamp":1793853754238,"version":"4.6.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T00:00:00Z","timestamp":1751673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T00:00:00Z","timestamp":1751673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-02648-7","type":"journal-article","created":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T01:28:44Z","timestamp":1751678924000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Squamous cell carcinoma antigen levels in women with cervical cancer and those without cervical cancer: a cross-sectional study among women of African descent"],"prefix":"10.1186","volume":"30","author":[{"given":"Maradona","family":"Isikhuemen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ezeanochie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chukwunwendu","family":"Okonkwo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friday","family":"Okonofua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,5]]},"reference":[{"key":"2648_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"2648_CR2","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/ijgo.13865","volume":"155","author":"N Bhatla","year":"2021","unstructured":"Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R. Cancer of the cervix uteri: 2021 update. Int J GynecolObstet. 2021;155:28\u201344.","journal-title":"Int J GynecolObstet"},{"key":"2648_CR3","unstructured":"HPV Information Centre. Human papillomavirus and related cancers. IARC. Fact Sheet, 2021."},{"key":"2648_CR4","unstructured":"World Health Organization. Global Strategy to Accelerate the Elimination of cervical cancer as a public health problem. WHO, 2020."},{"key":"2648_CR5","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/inthealth\/ihaa062","volume":"13","author":"HI Anyasi","year":"2021","unstructured":"Anyasi HI, Foss AM. A comparative analysis of cervical cancer prevention between Nigeria and Nordic countries that have experienced a decline in cervical cancer incidence. Int Health. 2021;13:307\u201317.","journal-title":"Int Health"},{"issue":"3","key":"2648_CR6","doi-asserted-by":"publisher","first-page":"295","DOI":"10.4161\/cbt.11.3.14686","volume":"11","author":"O Ibeanu","year":"2011","unstructured":"Ibeanu O. Molecular pathogenesis of cervical cancer. Cancer Biol Ther. 2011;11(3):295\u2013306.","journal-title":"Cancer Biol Ther"},{"key":"2648_CR7","doi-asserted-by":"publisher","first-page":"151","DOI":"10.4137\/CMO.S12017","volume":"7","author":"JN Eze","year":"2013","unstructured":"Eze JN, Emeka-Irem EN, Edegbe FO. A six-year study on the clinical presentation of cervical cancer and the management challenges encountered at a state teaching hospital in Southeast Nigeria. Clin Med Insights Oncol. 2013;7:151\u20138.","journal-title":"Clin Med Insights Oncol"},{"issue":"8","key":"2648_CR8","first-page":"1203","volume":"29","author":"AK Olusegun","year":"2008","unstructured":"Olusegun AK, Onwudiegwu U, Ogunniyi S, Loto O, Clement AA, et al. Trend in presentation of cervical cancer in Nigeria. Saudi Med J. 2008;29(8):1203\u20137.","journal-title":"Saudi Med J"},{"issue":"1","key":"2648_CR9","doi-asserted-by":"publisher","first-page":"238","DOI":"10.2174\/1874944501912010238","volume":"12","author":"WM Mohuba","year":"2019","unstructured":"Mohuba WM, Mothiba TM, Muthelo L. Initial clinical presentation of cervical cancer patients at Pietersburg Hospital, South Africa (2012\u20132014): a retrospective descriptive study. The Open Public Health J. 2019;12(1):238\u201346.","journal-title":"The Open Public Health J"},{"issue":"33","key":"2648_CR10","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000026960","volume":"100","author":"C Zhu","year":"2021","unstructured":"Zhu C, Zhang W, Wang X, Jiao L, Chen L, et al. Predictive value of preoperative serum squamous cell carcinoma antigen level for lymph node metastasis in early-stage cervical squamous cell carcinoma. Medicine. 2021;100(33): e26960.","journal-title":"Medicine"},{"issue":"2","key":"2648_CR11","first-page":"49","volume":"3","author":"KO Ngwogu","year":"2014","unstructured":"Ngwogu KO, Ndubuka G, Ngwogu AC. Prevalence of squamous cell carcinoma among cervical cancer patients in Igbos of Nigeria. IJCR. 2014;3(2):49\u201354.","journal-title":"IJCR"},{"issue":"2","key":"2648_CR12","doi-asserted-by":"publisher","first-page":"188503","DOI":"10.1016\/j.bbcan.2021.188503","volume":"1875","author":"M Zhang","year":"2021","unstructured":"Zhang M, Cheng S, Jin Y, Zhao Y, Wang Y. Role of CA125 in diagnosis, prediction and oncogenesis of ovarian cancer. Biochim et Biophys Acta Rev Cancer. 2021;1875(2):188503.","journal-title":"Biochim et Biophys Acta Rev Cancer"},{"key":"2648_CR13","doi-asserted-by":"publisher","first-page":"66","DOI":"10.4103\/2454-6798.209338","volume":"3","author":"R Sachan","year":"2017","unstructured":"Sachan R, Patel ML, Singh M, Sachan P, Shyam R. Role of squamous cell carcinoma antigen in monitoring of treatment response of cervical and vaginal malignancies. Asian J Oncol. 2017;3:66\u201370.","journal-title":"Asian J Oncol"},{"issue":"3","key":"2648_CR14","doi-asserted-by":"publisher","first-page":"313","DOI":"10.5301\/JBM.5000031","volume":"28","author":"MT Sandri","year":"2013","unstructured":"Sandri MT, Salvatici M, Mauro C, Radice D, Lentati P, et al. Detection of squamous cell carcinoma antigen with two systems in the follow-up of patients with cervical cancer. Int J Biol Markers. 2013;28(3):313\u20137.","journal-title":"Int J Biol Markers"},{"issue":"1","key":"2648_CR15","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ejso.2019.08.021","volume":"46","author":"Q Guo","year":"2020","unstructured":"Guo Q, Zhu J, Wu Y, Wen H, Xia L, Wu X, et al. Predictive value of pre-operative serum squamous cell carcinoma antigen (SCC-Ag) level on tumour recurrence in cervical squamous cell carcinoma patients treated with radical surgery: a single institution study. Eur J Surg Oncol. 2020;46(1):131\u20138.","journal-title":"Eur J Surg Oncol"},{"key":"2648_CR16","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/j.1525-1438.2006.00663.x","volume":"17","author":"KF Hus","year":"2007","unstructured":"Hus KF, Huang SC, Shiau AL, Cheng YM, Shen MR, et al. Increased expression level of squamous cell carcinoma antigen 2 and 1 ratio is associated with poor prognosis in early stage uterine cervical cancer. Int J Gynecol Cancer. 2007;17:174\u201381.","journal-title":"Int J Gynecol Cancer"},{"key":"2648_CR17","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1159\/000092775","volume":"27","author":"E Roijer","year":"2006","unstructured":"Roijer E, Bruijn H, Dahlen U, Hoor K, Lundin M. Squamous cell carcinoma antigen isoforms in serum from cervical cancer patients. Tumor Biol. 2006;27:142\u2013142.","journal-title":"Tumor Biol"},{"issue":"22","key":"2648_CR18","first-page":"351","volume":"3","author":"M Dipalo","year":"2015","unstructured":"Dipalo M, Gnocchi C, Aloe R, Lippi G. Analytical assessment of the novel Maglumi squamous cell carcinoma antigen (SCCA) immunoluminometric assay. Ann Transl Med. 2015;3(22):351.","journal-title":"Ann Transl Med"},{"key":"2648_CR19","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000292993","volume":"32","author":"H Verlooy","year":"1991","unstructured":"Verlooy H, Devos P, Janssens J, Mortelmans L, Gerits M, et al. Clinical significance of squamous cell carcinoma antigen in cancer of the human uterine cervix. GynecolObstet Invest. 1991;32:55\u20138.","journal-title":"GynecolObstet Invest"},{"issue":"4","key":"2648_CR20","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3802\/jgo.2013.24.4.321","volume":"24","author":"K Shimura","year":"2013","unstructured":"Shimura K, Mabuchi S, Yokoi T, Sasano T, Sawada K, et al. Utility of serum squamous cell carcinoma antigen levels at the time of recurrent cervical cancer diagnosis in determining the optimal treatment choice. J Gynecol Oncol. 2013;24(4):321\u20139.","journal-title":"J Gynecol Oncol"},{"key":"2648_CR21","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1159\/000030045","volume":"19","author":"GC Torre","year":"1998","unstructured":"Torre GC. SCC antigen in malignant and non-malignant squamous lesions. Tumor Biol. 1998;19:517\u201326.","journal-title":"Tumor Biol"},{"key":"2648_CR22","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/0090-8258(89)90164-9","volume":"34","author":"M Maiman","year":"1989","unstructured":"Maiman M, Feuer G, Fruchter RG, Shaw N, Boyce J. Value of squamous cell carcinoma antigen levels in invasive cervical carcinoma. Gynecol Oncol. 1989;34:312\u20136.","journal-title":"Gynecol Oncol"},{"key":"2648_CR23","first-page":"208","volume":"25","author":"C Chuenkamon","year":"2017","unstructured":"Chuenkamon C. Serum squamous cell carcinoma antigen and its application in cervical cancer patients. Thai J ObstetGynaecol. 2017;25:208\u201313.","journal-title":"Thai J ObstetGynaecol"},{"key":"2648_CR24","unstructured":"Dianbo Xu, Wang D, Wang S, Tian Y, Long Z et al. Correlation between squamous cell carcinoma antigen levels and the clinicopathological features early stage cervical squamous cell carcinoma and the predictive value of squamous cell carcinoma antigen combined with computed tomography scan for lymph node metastasis. Int J Gynecol Cancer, 2017; 0(0): 10.1097"},{"issue":"4","key":"2648_CR25","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3802\/jgo.2013.24.4.291","volume":"24","author":"B Kim","year":"2013","unstructured":"Kim B. Squamous cell carcinoma in cervical cancer and beyond. J Gynecol Oncol. 2013;24(4):291\u20132.","journal-title":"J Gynecol Oncol"},{"key":"2648_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2016.04.029","author":"M Salvatici","year":"2016","unstructured":"Salvatici M, Achilarre MT, Sandri MT, Boveri S, Vanna Z, Landoni F. Squamous cell carcinoma antigen (SCC-Ag) during follow-up of cervical cancer patients: role in early diagnosis of recurrence. Gynecol Oncol. 2016. https:\/\/doi.org\/10.1016\/j.ygyno.2016.04.029.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"2648_CR27","doi-asserted-by":"publisher","first-page":"287","DOI":"10.7150\/jca.10819","volume":"6","author":"Y Hu","year":"2015","unstructured":"Hu Y, Fan W, Zhang X, Liang P, Lin X, et al. Complementary roles of squamous cell carcinoma antigen and F-FDG PET\/CT in suspected recurrence of cervical squamous cell cancer. J Cancer. 2015;6(3):287\u201391.","journal-title":"J Cancer"},{"key":"2648_CR28","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ygyno.2020.05.313","volume":"159","author":"S Lee","year":"2020","unstructured":"Lee S, Lee J. The change of squamous cell carcinoma antigen levels can predict tumour recurrence and survival in patients with cervical cancer with definitive chemoradiotherapy. Gynecol Oncol. 2020;159:198.","journal-title":"Gynecol Oncol"},{"key":"2648_CR29","doi-asserted-by":"crossref","unstructured":"Liu Z, Shi H. Prognostic role of squamous cell carcinoma antigen in cervical cancer: a meta-analysis. Disease Markers, 2019; article ID: 6710352","DOI":"10.1155\/2019\/6710352"},{"key":"2648_CR30","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/bjc.2017.390","volume":"118","author":"S Markovina","year":"2018","unstructured":"Markovina S, Wang S, Henke L, Luke C, Pak S. Serum squamous cell carcinoma antigen as an early indicator of response during therapy of cervical cancer. British J Cancer. 2018;118:72\u20138.","journal-title":"British J Cancer"},{"issue":"6","key":"2648_CR31","doi-asserted-by":"publisher","first-page":"663","DOI":"10.3109\/02841869309092449","volume":"32","author":"H Shirato","year":"1993","unstructured":"Shirato H, Ichimura W, Wakushima H, Ntshioka T, Suzuki K. Squamous cell carcinoma antigen in serum for monitoring of head and neck and uterine cervical squamous cell carcinomas after radiotherapy. Acta Oncol. 1993;32(6):663\u20136.","journal-title":"Acta Oncol"},{"issue":"10","key":"2648_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0204334","volume":"13","author":"Y Wen","year":"2018","unstructured":"Wen Y, Cheng T, Chen X, Huang W, Peng H, et al. Elevated circulating tumour cells and squamous cell carcinoma antigen levels predict poor survival for patients with locally advanced cervical cancer treated with radiotherapy. PLoS ONE. 2018;13(10): e0204334.","journal-title":"PLoS ONE"},{"key":"2648_CR33","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1039\/C9AY00667B","volume":"11","author":"D Lu","year":"2019","unstructured":"Lu D, Xia J, Deng Z, Cao X. Detection of squamous cell carcinoma antigen in cervical cancer by surface-enhanced Raman scattering-based immunoassay. Anal Methods. 2019;11:2809\u201318.","journal-title":"Anal Methods"},{"issue":"1","key":"2648_CR34","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0360-3016(01)01805-3","volume":"52","author":"E Pras","year":"2002","unstructured":"Pras E, Willemse PH, Canrinus AA, Bruijn HW, Sluiter WJ, et al. Serum squamous cell carcinoma antigen and cyfra 21\u20131 in cervical cancer treatment. Int J Radiation Oncol Biol Phys. 2002;52(1):23\u201332.","journal-title":"Int J Radiation Oncol Biol Phys"},{"issue":"11","key":"2648_CR35","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1016\/0277-5379(89)90297-6","volume":"25","author":"W Meier","year":"1989","unstructured":"Meier W, Stieber P, Schneider A, Fateh-Moghadam AF, Hepp H. Experiences with SCC Antigen, a new tumour marker for cervical carcinoma. Eur J Cancer Clin Oncol. 1989;25(11):1555\u20139.","journal-title":"Eur J Cancer Clin Oncol"},{"key":"2648_CR36","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12885-020-6630-0","volume":"20","author":"S Ye","year":"2020","unstructured":"Ye S, Sun X, Kang B, Wu F, Zheng Z, et al. The kinetic profile and clinical implication of SCC-Ag in squamous cervical cancer patients undergoing radical hysterectomy using the Simoa assay: a prospective observational study. BMC Cancer. 2020;20:138.","journal-title":"BMC Cancer"},{"issue":"3","key":"2648_CR37","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3923\/ijcr.2006.212.218","volume":"2","author":"ML Looi","year":"2006","unstructured":"Looi ML, Hatta AZ, Aishah MA, Baizurah MH, Zurinah WN, et al. Serum levels of squamous cell carcinoma antigen and CA 125 in cervical intraepithelial neoplasia and invasive squamous cell carcinoma of the uterine cervix. Int J Cancer Res. 2006;2(3):212\u20138.","journal-title":"Int J Cancer Res"},{"issue":"11","key":"2648_CR38","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1200\/JCO.1994.12.11.2309","volume":"12","author":"G Scambia","year":"1994","unstructured":"Scambia G, Benedetti P, Foti E, Amoroso M, Salerno G, et al. Squamous cell carcinoma antigen: prognostic significance and role in the monitoring of neoadjuvant chemotherapy response in cervical cancer. J Clin Oncol. 1994;12(11):2309\u201316.","journal-title":"J Clin Oncol"},{"key":"2648_CR39","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/S0002-9378(12)90850-9","volume":"168","author":"P Rose","year":"1993","unstructured":"Rose P, Baker S, Fournier L, Nelson B, Hunter R. Serum squamous cell carcinoma antigen levels in invasive cervical cancer: Prediction of response and recurrence. Am J ObstetGynecol. 1993;168:942\u20136.","journal-title":"Am J ObstetGynecol"},{"key":"2648_CR40","doi-asserted-by":"publisher","first-page":"184","DOI":"10.4103\/ccij.ccij_43_17","volume":"6","author":"M Singh","year":"2017","unstructured":"Singh M, Sachan P, Patel ML, Shyam R. Squamous cell carcinoma antigen reproducible marker and its clinicopathologic correlation with preinvasive and invasive cervical cancer. Clin Cancer Investig J. 2017;6:184\u20139.","journal-title":"Clin Cancer Investig J"},{"issue":"3","key":"2648_CR41","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3857\/roj.2011.29.3.191","volume":"29","author":"BK Jeong","year":"2011","unstructured":"Jeong BK, Choi DH, Huh SJ, Park W, Bae DS, et al. The role of squamous cell carcinoma antigen as a prognostic and predictive factor in carcinoma of uterine cervix. Radiat Oncol J. 2011;29(3):191\u20138.","journal-title":"Radiat Oncol J"},{"key":"2648_CR42","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/ijc.2910470311","volume":"47","author":"PA Brioschi","year":"1991","unstructured":"Brioschi PA, Bischof P, Delafosse C, Krauer F. Squamous cell carcinoma antigen (SCC-A) values related to clinical outcome of pre-invasive and invasive cervical carcinoma. Int J Cancer. 1991;47:376\u20139.","journal-title":"Int J Cancer"},{"issue":"5","key":"2648_CR43","doi-asserted-by":"publisher","first-page":"368","DOI":"10.5468\/ogs.2015.58.5.368","volume":"58","author":"HK Ryu","year":"2015","unstructured":"Ryu HK, Baek JS, Kang WD, Kim SM. The prognostic value of squamous cell carcinoma antigen for predicting tumour recurrence in cervical squamous cell caecinoma patients. Obstet Gynecol Sci. 2015;58(5):368\u201376.","journal-title":"Obstet Gynecol Sci"},{"issue":"5","key":"2648_CR44","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.3390\/diagnostics12051065","volume":"12","author":"H Zhu","year":"2022","unstructured":"Zhu H. Squamous cell carcinoma antigen: clinical application and research status. Diagnostics. 2022;12(5):1065.","journal-title":"Diagnostics"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02648-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-02648-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02648-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T01:28:48Z","timestamp":1751678928000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-02648-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,5]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2648"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-02648-7","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,5]]},"assertion":[{"value":"27 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval was obtained from the Ethics and Research Committee of the University of Benin Teaching Hospital with Protocol Number ADM\/E22\/A\/VOL.VII\/14831264. Written informed consent was obtained from the study participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"573"}}